BiomX Inc.
BiomX Inc. (PHGE): 5 pipeline candidates · 1 upcoming catalyst · ~1 mo cash runway · 3 clinical trials. Updated within the last hour.
BioSniper Score
6-factor signal · derived from public data
1.0 months
D/E -4.69 · 0% dilution
Lead: Phase 2
5 candidates
1 upcoming, next in ~12d
0 buys · 4 sells (180d)
A transparent, data-derived signal for BiomX Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$6.4M
Cash
$1.2M
Quarterly Burn
$5.4M
Runway
1.0 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
9
Total value held
$616K
| Holder | Shares | Value |
|---|---|---|
| deerfield management company, l.p. | 131,272 | $493K |
| morgan stanley | 19,100 | $72K |
| jane street group, llc | 11,829 | $44K |
| barclays plc | 1,316 | $5K |
| royal bank of canada | 251 | $1K |
| osaic holdings, inc. | 200 | $750 |
| sbi securities co., ltd. | 20 | $75 |
| cwm, llc | 1 | $4 |
| danske bank a/s | 1 | $4 |
Frequently asked questions
How many drug candidates are in BiomX Inc.'s pipeline?
BiomX Inc. (PHGE) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is BiomX Inc.'s lead drug candidate?
BiomX Inc.'s most advanced tracked candidate is bx004 (Phase 2) for Chronic Pseudomonas Aeruginosa Infection.
What is BiomX Inc.'s next catalyst?
BiomX Inc.'s next tracked catalyst is a Phase2_Topline event — "Phase 2 Readout: bx004" — expected June 30, 2026.
What is BiomX Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, BiomX Inc. has approximately 1.0 months of cash runway.
What is BiomX Inc.'s market capitalization?
BiomX Inc.'s market capitalization is approximately $6.4M.
Get the full picture on BiomX Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.